彻底改变急性髓性白血病的治疗方法:对基于免疫的疗法进行系统审查

Ugochi Ebinama1, Binsah George2

  • 1Department of Internal Medicine, The University of Texas Health Sciences Center at Houston, McGovern Medical School, Houston, TX, USA.

Discover oncology
|January 26, 2025
PubMed
概括

使用单克隆抗体的向免疫疗法为治疗急性髓性白血病 (AML) 提供了一个有希望的新方法,特别是在复发或耐药病例中. 本综述探讨了AML治疗中的抗体机制和挑战.

相关概念视频

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K